Factors Influencing Clinical Initiation of Tafamidis Therapy for Transthyretin Amyloidosis Cardiomyopathy: A Canadian Referral Center Experience. Article uri icon

Overview

publication date

  • September 7, 2024

Identity

Scopus Document Identifier

  • 85204636838

Digital Object Identifier (DOI)

  • 10.1016/j.cjca.2024.08.277

PubMed ID

  • 39182757

Additional Document Info

volume

  • 40

issue

  • 12